Neonatal thrombocytopenia

Area of Science:

• Neonatal Medicine
• Hematology
• Pediatric Critical Care

Background:

• Neonatal thrombocytopenia is a frequent clinical challenge with diverse causes.
• Early-onset thrombocytopenia often stems from placental insufficiency, while late-onset cases are frequently linked to sepsis or necrotizing enterocolitis.
• Profound thrombocytopenia in unstable neonates is associated with poor outcomes.

Purpose of the Study:

• To review the current understanding of neonatal thrombocytopenia.
• To highlight the lack of evidence-based guidelines for platelet transfusion in sick neonates.
• To emphasize the critical need for randomized trials to establish safe platelet count thresholds.

Main Methods:

• This review synthesizes existing literature on neonatal thrombocytopenia.
• It analyzes common etiologies and clinical presentations.
• It critically evaluates current transfusion practices and identifies research gaps.

Main Results:

• Common causes include placental insufficiency, immune thrombocytopenias, congenital infections, asphyxia, bacterial sepsis, and necrotizing enterocolitis.
• Platelet transfusion is the primary therapy, but optimal thresholds remain undefined.
• No randomized trials exist to guide transfusion decisions in sick neonates.

Conclusions:

• The optimal platelet transfusion threshold for sick neonates is currently unknown.
• Existing guidelines lack robust evidence from randomized controlled trials.
• Urgent, well-designed trials are essential to define safe and effective platelet transfusion strategies for neonatal thrombocytopenia.